Zorifertinib is a potent epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor designed with the unique capability to penetrate the blood-brain barrier. This targeted therapeutic is indicated… Read more
Zorifertinib is a potent epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor designed with the unique capability to penetrate the blood-brain barrier. This targeted therapeutic is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR mutations, particularly when central nervous system metastases are present. To support the rigorous demands of pharmaceutical analysis, this category of Zorifertinib reference standards provides essential tools for analytical method development and validation. This collection includes high-quality Zorifertinib impurities, metabolites, and stable isotope labelled compounds, which are critical for accurate impurity profiling and quantitative bioanalytical assays. Pharmaceutical laboratories rely on these specialized reference materials to ensure compliance with quality control standards, allowing for the precise detection and quantification of the parent drug and its degradation products throughout the analytical lifecycle.